AI assistant
HENRY SCHEIN INC — Capital/Financing Update 2013
Nov 26, 2013
30735_rns_2013-11-26_41a26db0-0e01-4ff4-a547-58bb9e71151d.zip
Capital/Financing Update
Open in viewerOpens in your device viewer
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 26, 2013
Henry Schein, Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 0-27078 | 11-3136595 |
|---|---|---|
| (State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
| 135 Duryea Road, Melville, New York | 11747 |
|---|---|
| (Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: (631) 843-5500
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01. Regulation FD Disclosure.
On November 26, 2013, Henry Schein, Inc. (the Company) issued a press release announcing that it has entered into an agreement to acquire a 60% interest in BioHorizons, Inc., a U.S.-based manufacturer of advanced dental implants sold internationally. In connection with the acquisition, the Company announced that it has revised its 2014 financial guidance.
The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
The information set forth in Item 7.01 is deemed to be furnished and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
99.1 Press Release dated November 26, 2013.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| /s/ Walter Siegel |
|---|
| Walter Siegel |
| Senior Vice President and General Counsel |